| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053379 4-aryl-2-anilino-pyrimidines |
| 02/28/2013 | US20130053378 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053376 Novel tyrosine kinase inhibitors |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053374 Ophthalmic composition |
| 02/28/2013 | US20130053373 Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053370 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES |
| 02/28/2013 | US20130053369 Tetrahydrobenzothiophene compound |
| 02/28/2013 | US20130053368 Methods for treatment of parkinson's disease |
| 02/28/2013 | US20130053367 Compounds and methods of treating diabetes |
| 02/28/2013 | US20130053366 Compounds and methods for treatment of hypertension |
| 02/28/2013 | US20130053365 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/28/2013 | US20130053364 Sulphone Compounds and Methods of Making and Using Same |
| 02/28/2013 | US20130053363 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 02/28/2013 | US20130053362 Heterocyclic compounds and uses thereof |
| 02/28/2013 | US20130053361 Therapeutic isoxazole compounds |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053358 Transdermally absorbable donepezil-containing preparation |
| 02/28/2013 | US20130053357 Skin irritation suppressant and transdermal preparation |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053355 Products for anti-inflammation support |
| 02/28/2013 | US20130053354 Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative |
| 02/28/2013 | US20130053353 Compositions, gels and foams with rheology modulators and uses |
| 02/28/2013 | US20130053352 Diazeniumdiolate cyclopentyl derivatives |
| 02/28/2013 | US20130053351 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 02/28/2013 | US20130053350 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053347 Pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053343 Compounds and methods for inhibiting serotonin synthesis |
| 02/28/2013 | US20130053341 Therapeutic compounds and related methods of use |
| 02/28/2013 | US20130053340 Intestinal barrier integrity |
| 02/28/2013 | US20130053339 Synergistic phytochemical composition and a process for preparation thereof |
| 02/28/2013 | US20130053338 Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta Cells |
| 02/28/2013 | US20130053337 Guanidinylated aminoglycoside-lipid conjugates |
| 02/28/2013 | US20130053336 Treatment of chlamydiaceae infections by means of beta-lactams |
| 02/28/2013 | US20130053335 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine |
| 02/28/2013 | US20130053334 Monomers and oligonucleotides comprising cycloaddition adduct(s) |
| 02/28/2013 | US20130053333 Aminoquinoline Derivatives |
| 02/28/2013 | US20130053332 Use |
| 02/28/2013 | US20130053326 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 02/28/2013 | US20130053325 Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130052354 Evaporation operative materials having low environmental impact |
| 02/28/2013 | US20130052286 Composition for treatment of aesthenopia |
| 02/28/2013 | US20130052283 Methods of Treating a Subject with Benign Prostate Hyperplasia |
| 02/28/2013 | US20130052281 Novel compounds |
| 02/28/2013 | US20130052280 Use of thebromine for lowering central blood pressure |
| 02/28/2013 | US20130052279 Reverse micelle system comprising metal ions and use thereof |
| 02/28/2013 | US20130052274 Nutritional compositions including exogenous vitamin k2 |
| 02/28/2013 | US20130052271 Compositions and Methods for Treating Pain |
| 02/28/2013 | US20130052268 Compositions and methods for treatment of parkinson's disease |
| 02/28/2013 | US20130052266 TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
| 02/28/2013 | US20130052265 Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment |
| 02/28/2013 | US20130052264 Controlled-release pharmaceutical composition including tamsulosin or pharmaceutically acceptable salts thereof, and oral formulation including the same |
| 02/28/2013 | US20130052263 Pharmaceutical compositions with synchronized solubilizer release |
| 02/28/2013 | US20130052262 Dabigatran etexilate-containing oral pharmaceutical composition |
| 02/28/2013 | US20130052261 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| 02/28/2013 | US20130052260 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 02/28/2013 | US20130052259 Liposomes comprising amphipathic drugs and method for their preparation |
| 02/28/2013 | US20130052257 Antimicrobial hydrogel wound dressing |
| 02/28/2013 | US20130052254 System and method for a piezoelectric scaffold for tissue growth and repair |
| 02/28/2013 | US20130052253 Flavoring of drug-containing chewing gums |
| 02/28/2013 | US20130052251 Composition and method for treating nosebleeds |
| 02/28/2013 | US20130052249 Antimicrobial composition |
| 02/28/2013 | US20130052248 Item of clothing for daily pharmacological treatment of a fungal infection |
| 02/28/2013 | US20130052241 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
| 02/28/2013 | US20130052239 Formulation |
| 02/28/2013 | US20130052238 Gene delivery of oct4 and sirt1 and pharmaceutical compositions thereof |
| 02/28/2013 | US20130052237 Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations |
| 02/28/2013 | US20130052234 Edible strips |
| 02/28/2013 | US20130052231 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 02/28/2013 | US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 02/28/2013 | US20130052222 Influenza nucleic acid molecules and vaccines made therefrom |
| 02/28/2013 | US20130052217 Tumor vaccination involving a humoral immune response against self-proteins |
| 02/28/2013 | US20130052207 Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma |
| 02/28/2013 | US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052199 Molecular Determinants of Myeloma Bone Disease and Uses Thereof |
| 02/28/2013 | US20130052190 CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions |
| 02/28/2013 | US20130052189 Method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052178 Cholesterol ester for reducing cholesterol absorption |
| 02/28/2013 | US20130052176 Aptamer for ngf and use thereof |
| 02/28/2013 | US20130052175 Oil suspension-based molded food products |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052161 Inhibitors of flaviviridae viruses |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/28/2013 | US20130052159 Methods for treatment of microbial disorders |
| 02/28/2013 | US20130052156 Antiviral method |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | US20130052153 Method of preparing hydrogel structure |